Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between

Animals Apoptosis / genetics Cell Cycle / genetics Cell Differentiation / genetics Coculture Techniques Embryonic Development / genetics Endothelial Cells / cytology Hematopoiesis / genetics Hematopoietic Stem Cells / cytology Histones / metabolism Human Embryonic Stem Cells / cytology Humans Methylation Mice Mice, Knockout Myeloid-Lymphoid Leukemia Protein / genetics Oncogene Proteins, Fusion / genetics

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
06 2019
Historique:
received: 18 07 2018
accepted: 21 01 2019
pubmed: 27 1 2019
medline: 19 5 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

The t(4;11)(q21;q23) translocation is associated with high-risk infant pro-B-cell acute lymphoblastic leukemia and arises prenatally during embryonic/fetal hematopoiesis. The developmental/pathogenic contribution of the t(4;11)-resulting

Identifiants

DOI: 10.3324/haematol.2018.202044 PMID: 30679325 PMC: PMC6545840
pubmed: 30679325
pii: haematol.2018.202044
doi: 10.3324/haematol.2018.202044
pmc: PMC6545840
doi:

Substances chimiques

Histones 0
MLL-AF4 fusion protein, human 0
Oncogene Proteins, Fusion 0
Myeloid-Lymphoid Leukemia Protein 149025-06-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1201

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008975/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S036113/1
Pays : United Kingdom

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

Oncogene. 2001 May 10;20(21):2636-46
pubmed: 11420675
Cancer Cell. 2014 Dec 8;26(6):896-908
pubmed: 25464900
Blood. 2014 Nov 13;124(20):3065-75
pubmed: 25185710
Oncotarget. 2017 Jul 26;8(47):81936-81941
pubmed: 29137234
Stem Cells Dev. 2012 Jun 10;21(9):1549-58
pubmed: 21936705
Blood. 2006 Jul 15;108(2):669-77
pubmed: 16551973
Oncotarget. 2016 Jun 7;7(23):35341-52
pubmed: 27175594
Trends Mol Med. 2002 Aug;8(8):396-405
pubmed: 12127726
Haematologica. 2019 Jun;104(6):1176-1188
pubmed: 30679323
Leuk Res. 2011 Mar;35(3):299-300
pubmed: 20952059
Genes Dev. 2008 Dec 15;22(24):3403-8
pubmed: 19141473
Cancer Res. 2010 May 15;70(10):4185-94
pubmed: 20442289
Blood. 2010 Apr 29;115(17):3570-9
pubmed: 20194896
Stem Cell Reports. 2016 Oct 11;7(4):602-618
pubmed: 27666791
Leukemia. 2007 Jun;21(6):1232-8
pubmed: 17410185
J Exp Med. 2009 Dec 21;206(13):3131-41
pubmed: 19995953
Eur J Haematol. 2009 Nov;83(5):406-19
pubmed: 19558506
Stem Cell Rev Rep. 2010 Jun;6(2):215-23
pubmed: 20180051
Mol Ther. 2015 Jan;23(1):158-70
pubmed: 25292191
Stem Cells. 2011 Apr;29(4):736-41
pubmed: 21328509
Leukemia. 2008 Aug;22(8):1475-8
pubmed: 18698324
Leukemia. 2011 Jan;25(1):135-44
pubmed: 21030982
Oncotarget. 2015 Sep 22;6(28):25784-800
pubmed: 26329759
Am J Blood Res. 2016 Sep 15;6(3):28-45
pubmed: 27679741
Immunity. 2004 Jul;21(1):31-41
pubmed: 15345218
Leukemia. 2016 Mar;30(3):674-82
pubmed: 26500142
Stem Cell Reports. 2014 Dec 9;3(6):1118-31
pubmed: 25458894
Cell Rep. 2016 Jul 26;16(4):1039-1054
pubmed: 27396339
Cell Res. 2012 Jun;22(6):986-1002
pubmed: 22212479
Leukemia. 2004 Mar;18(3):491-8
pubmed: 14724650
Cancer Cell. 2016 Nov 14;30(5):737-749
pubmed: 27846391
Exp Hematol. 2017 Jan;45:85-93.e2
pubmed: 27693385
Stem Cells. 2017 Jul;35(7):1687-1703
pubmed: 28472853
Blood. 2015 Dec 17;126(25):2676-85
pubmed: 26463423
Cell Rep. 2013 Jan 31;3(1):116-27
pubmed: 23352661
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2180-2185
pubmed: 29386396
Haematologica. 2018 Dec;103(12):e571-e574
pubmed: 29903765
Nat Genet. 2015 Apr;47(4):330-7
pubmed: 25730765
Blood. 2005 Jan 15;105(2):617-26
pubmed: 15374881
Leukemia. 2011 Mar;25(3):400-10
pubmed: 21135858
Stem Cells. 2010 Sep;28(9):1568-70
pubmed: 20641038
Mol Ther. 2010 Dec;18(12):2173-81
pubmed: 20736931
Br J Haematol. 2011 Jan;152(2):141-54
pubmed: 21118195
Cancer Cell. 2008 Nov 4;14(5):355-68
pubmed: 18977325
Leukemia. 2011 May;25(5):888-91
pubmed: 21311557
Oncogene. 2006 May 25;25(22):3093-103
pubmed: 16607274
Nature. 2010 Mar 4;464(7285):116-20
pubmed: 20154729
Haematologica. 2014 Jul;99(7):1168-75
pubmed: 24727813
Blood. 2017 Apr 20;129(16):2217-2223
pubmed: 28179274
Mol Ther. 2004 Dec;10(6):1109-20
pubmed: 15564142
Leukemia. 2014 Mar;28(3):666-74
pubmed: 24240202
Cancer Res. 2016 Apr 15;76(8):2478-89
pubmed: 26837759
Blood. 2011 May 5;117(18):4746-58
pubmed: 21389315
Curr Protoc Cell Biol. 2007 Sep;Chapter 23:Unit 23.6
pubmed: 18228507
Leukemia. 2015 Aug;29(8):1741-53
pubmed: 25778099
Tissue Eng Part C Methods. 2012 May;18(5):387-96
pubmed: 22136131
Cytotherapy. 2010;12(1):45-9
pubmed: 19929453
Nat Rev Cancer. 2006 Mar;6(3):193-203
pubmed: 16467884
Cytotherapy. 2006;8(6):530-41
pubmed: 17148029
Blood. 2005 Oct 1;106(7):2484-90
pubmed: 15956279
Acta Haematol. 2011;125(3):130-5
pubmed: 21150180
Leuk Res. 2011 Mar;35(3):305-9
pubmed: 20869771
Blood. 2007 Feb 15;109(4):1472-8
pubmed: 17047146
Haematologica. 2013 Jun;98(6):937-44
pubmed: 23403319
Nature. 1993 May 27;363(6427):358-60
pubmed: 8497319
Blood. 2013 May 9;121(19):3867-78, S1-3
pubmed: 23479570

Auteurs

Clara Bueno (C)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain cbueno@carrerasresearch.org pmenendez@carrerasresearch.org.
Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.

Fernando J Calero-Nieto (FJ)

Department of Hematology, Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK.

Xiaonan Wang (X)

Department of Hematology, Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK.

Rafael Valdés-Mas (R)

Dreamgenics S.L. Oviedo. Spain.

Francisco Gutiérrez-Agüera (F)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain.

Heleia Roca-Ho (H)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain.

Veronica Ayllon (V)

GENyO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government and University of Granada, Department of Biochemistry and Molecular Biology, Granada, Spain.

Pedro J Real (PJ)

GENyO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government and University of Granada, Department of Biochemistry and Molecular Biology, Granada, Spain.

David Arambilet (D)

Programa de Cáncer, Instituto Hospital del Mar de Investigaciones Médicas. Barcelona. Spain.

Lluis Espinosa (L)

Programa de Cáncer, Instituto Hospital del Mar de Investigaciones Médicas. Barcelona. Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.

Raul Torres-Ruiz (R)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain.

Antonio Agraz-Doblas (A)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain.
Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.

Ignacio Varela (I)

Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.

Jasper de Boer (J)

Cancer Section, UCL Great Ormond Street Institute of Child Health, London, UK.

Anna Bigas (A)

Programa de Cáncer, Instituto Hospital del Mar de Investigaciones Médicas. Barcelona. Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.

Bertie Gottgens (B)

Department of Hematology, Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK.

Rolf Marschalek (R)

Institute of Pharmaceutical Biology, Goethe-University, Frankfurt, Germany.

Pablo Menendez (P)

Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain cbueno@carrerasresearch.org pmenendez@carrerasresearch.org.
Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.
Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Mort cellulaire › Mort cellulaire régulée › Apoptose › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Cycle cellulaire › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Différenciation cellulaire › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Techniques d'investigation › Techniques in vitro › Techniques de culture › Techniques de coculture › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Développement embryonnaire et foetal › Développement embryonnaire › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hématopoïèse › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système hématopoïétique › Cellules de la moelle osseuse › Cellules souches hématopoïétiques › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Nucléoprotéines › Histone › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches pluripotentes › Cellules souches embryonnaires › Cellules souches embryonnaires humaines › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Métabolisme › Alkylation › Méthylation › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Protéine de la leucémie myéloïde-lymphoïde › Enhanced hemato-endothelial specification...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines de fusion oncogènes › Enhanced hemato-endothelial specification...